EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes

Teresa Rodriguez-Calvo, Jutta E Laiho, Maarit Oikarinen, Pouria Akhbari, Christine Flaxman, Thomas Worthington, Paola Apaolaza, John S Kaddis, Irina Kusmartseva, Sisko Tauriainen, Martha Campbell-Thompson, Mark A Atkinson und 6 weitere

Diabetologia · 2025-06 · 68 (6) · 1197-1210

DOI: 10.1007/s00125-025-06384-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, online erschienen am 17.03.2025. Verfasst von Teresa Rodriguez-Calvo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany. teresa.rodrig…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Islets of Langerhans, Enterovirus, Capsid Proteins. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European comission frame programme 7, European Foundation for the Study of Diabetes, Juvenile Diabetes Research Foundation International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Earlier studies of pancreases from donors with type 1 diabetes demonstrated enteroviral capsid protein VP1 in beta cells. In the context of a multidisciplinary approach undertaken by the nPOD-Virus group, we assessed VP1 positivity in pancreas and other tissues (spleen, duodenum and pancreatic lymph nodes) from 188 organ donors, including donors with type 1 diabetes and donors expressing autoantibody risk markers. We also investigated whether VP1 positivity is linked to the hyperexpression of HLA class I (HLA-I) molecules in islet cells.

Methods

Organ donor tissues were collected by the Network for Pancreatic Organ Donors with Diabetes (nPOD) from donors without diabetes (ND, n =76), donors expressing a single or multiple diabetes-associated autoantibodies (AAb + , n =20; AAb ++ , n =9) and donors with type 1 diabetes with residual insulin-containing islets (T1D-ICIs, n =41) or only insulin-deficient islets (T1D-IDIs, n =42). VP1 was assessed using immunohistochemistry (IHC) and HLA-I using IHC and immunofluorescence, in two independent laboratories. We determined assay concordance across laboratories and overall occurrence of positive assays, on a case-by-case basis and between donor groups.

Results

Islet cell VP1 positivity was detected in most T1D-ICI donors (77.5%) vs only 38.2% of ND donors ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Islets of LangerhansEnterovirusCapsid ProteinsHistocompatibility Antigens Class IHumansMaleTissue DonorsFemaleAdultMiddle AgedYoung AdultAdolescentAutoantibodiesPancreas

Stichwörter der Autor:innen

AutoimmunityEnterovirusHLA-I moleculesImmunofluorescenceImmunohistochemistryPancreasType 1 diabetes

Substanzen

Capsid ProteinsHistocompatibility Antigens Class IAutoantibodies

Autor:innen und Institutionen

  • Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany. teresa.rodriguez@helmholtz-munich.de.
  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Islet Biology Exeter (IBEx), Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK.
  • Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Department of Diabetes and Cancer Discovery Science, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, CA, USA.
  • Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.

Förderung

  • European comission frame programme 7
  • European Foundation for the Study of Diabetes
  • Juvenile Diabetes Research Foundation International
  • NIDDK NIH HHS
  • Leona M. and Harry B. Helmsley Charitable Trust
  • Medical Research Council
  • Human Islet Research Network
  • Steve Morgan Foundation DUK/JDRF

Zitieren

APA

Rodriguez-Calvo, T., Laiho, J. E., Oikarinen, M., Akhbari, P., Flaxman, C., Worthington, T., Apaolaza, P., Kaddis, J. S., Kusmartseva, I., Tauriainen, S., Campbell-Thompson, M., Atkinson, M. A., von Herrath, M., Hyöty, H., Morgan, N. G., Pugliese, A., Richardson, S. J., & nPOD-Virus group (2025). Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes. Diabetologia, 68(6), 1197-1210. https://doi.org/10.1007/s00125-025-06384-9

Vancouver

Rodriguez-Calvo T, Laiho JE, Oikarinen M, Akhbari P, Flaxman C, Worthington T, et al. Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes. Diabetologia. 2025;68(6):1197-1210. doi:10.1007/s00125-025-06384-9

BibTeX
@article{RodriguezCalvo2025,
  author = {Rodriguez-Calvo, Teresa and Laiho, Jutta E and Oikarinen, Maarit and Akhbari, Pouria and Flaxman, Christine and Worthington, Thomas and Apaolaza, Paola and Kaddis, John S and Kusmartseva, Irina and Tauriainen, Sisko and Campbell-Thompson, Martha and Atkinson, Mark A and von Herrath, Matthias and Hyöty, Heikki and Morgan, Noel G and Pugliese, Alberto and Richardson, Sarah J and nPOD-Virus group, nPOD-Virus group},
  title = {Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes},
  journal = {Diabetologia},
  year = {2025},
  volume = {68},
  number = {6},
  pages = {1197--1210},
  doi = {10.1007/s00125-025-06384-9}
}
Kostenlos starten →